The R&D investment in the biopharmaceutical industry is strong, with a total of over 50 bil

[Pharmaceutical Network Industry News] In recent years, with the advancement of policies such as centralized procurement and the increasingly fierce market competition, the pharmaceutical industry has accelerated the transformatio...

2021.12.14 The Yangtze River Delta, which accounts for nearly 30% of the national biopharmaceut

For the development of China's biopharmaceutical industry, it has become a top priority to improve the ability of independent innovation, focus on solving major technical problems that hinder the development of the industry, a...